K952361

Substantially Equivalent

ABUSIGN DOA 2, DOA, COC/THC, DOA2, BIOSIGN DOA2, COC/THC

Applicant: Princeton BioMeditech Corp.
Product code: DIO
Advisory panel: Clinical Toxicology
Date received: 1995-05-08
Decision date: 1995-10-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.